{
    "items": [
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://iuk-business-connect.org.uk/casestudy/ai-powered-cancer-immunotherapy-discovery-could-be-a-step-closer/?ref=image\" title=\"\" target=\"_blank\" rel=\"noopener external\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/ai-powered-cancer-immunotherapy-discovery-could-be-a-step-closer/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/ai-powered-cancer-immunotherapy-discovery-could-be-a-step-closer/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/ai-powered-cancer-immunotherapy-discovery-could-be-a-step-closer/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/ai-powered-cancer-immunotherapy-discovery-could-be-a-step-closer/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://iuk-business-connect.org.uk/casestudy/ai-powered-cancer-immunotherapy-discovery-could-be-a-step-closer/\" title=\"TechBio startup, Exogene, is leveraging artificial intelligence (AI) to develop innovative immunotherapies with the potential to eliminate untreatable solid tumours in cancer patients. Through a collaboration with German company Alithea Bio, Exogene hopes to speed up cancer immunotherapy discovery and make it more cost-effective.\" itemprop=\"name\" target=\"_blank\" class=\"state-published\" rel=\"noopener external\">AI-powered cancer immunotherapy discovery could be a step closer</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">28 November 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">TechBio startup, Exogene, is leveraging artificial intelligence (AI) to develop innovative immunotherapies with the potential to eliminate untreatable solid tumours in cancer patients. Through a collaboration with German company Alithea Bio, Exogene hopes to speed up cancer immunotherapy discovery and make it more cost-effective.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://iuk-business-connect.org.uk/casestudy/ai-powered-cancer-immunotherapy-discovery-could-be-a-step-closer/?ref=image\" title=\"\" target=\"_blank\" rel=\"noopener external\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-could-be-a-step-closer-to-ai-powered-immunotherapy-discovery/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"A photo of the Exogene team working in their laboratory.\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-could-be-a-step-closer-to-ai-powered-immunotherapy-discovery/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-could-be-a-step-closer-to-ai-powered-immunotherapy-discovery/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-could-be-a-step-closer-to-ai-powered-immunotherapy-discovery/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://iuk-business-connect.org.uk/casestudy/ai-powered-cancer-immunotherapy-discovery-could-be-a-step-closer/\" title=\"Through UK-Germany Collaborative R&amp;D funding, Exogene is collaborating with the German company Alithea Bio, aiming to accelerate cancer immunotherapy discovery and make it more cost-effective.\" itemprop=\"name\" target=\"_blank\" class=\"state-published\" rel=\"noopener external\">Exogene could be a step closer to AI-powered immunotherapy discovery</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">11 November 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Through UK-Germany Collaborative R&amp;D funding, Exogene is collaborating with the German company Alithea Bio, aiming to accelerate cancer immunotherapy discovery and make it more cost-effective.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-to-showcase-breakthroughs-on-cancer-vaccine-development-at-sitc-2024-insight-into-a-double-blind-phase-i-iia-clinical-trial?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-to-showcase-breakthroughs-on-cancer-vaccine-development-at-sitc-2024-insight-into-a-double-blind-phase-i-iia-clinical-trial/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"A syringe being injected into an arm\"\n             srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-to-showcase-breakthroughs-on-cancer-vaccine-development-at-sitc-2024-insight-into-a-double-blind-phase-i-iia-clinical-trial/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-to-showcase-breakthroughs-on-cancer-vaccine-development-at-sitc-2024-insight-into-a-double-blind-phase-i-iia-clinical-trial/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-to-showcase-breakthroughs-on-cancer-vaccine-development-at-sitc-2024-insight-into-a-double-blind-phase-i-iia-clinical-trial/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-to-showcase-breakthroughs-on-cancer-vaccine-development-at-sitc-2024-insight-into-a-double-blind-phase-i-iia-clinical-trial\" title=\"Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today announces that it will be presenting three posters on its pioneering cancer vaccine discovery and development, including one that has been recognised as a \u2018top 100\u2019 poster presentation, at the Society for Immunotherapy of Cancer (SITC) 2024, held in Houston, US, from 6-10th November.\" itemprop=\"name\" class=\"state-published\">Infinitopes to showcase breakthroughs on cancer vaccine development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">8 November 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today announces that it will be presenting three posters on its pioneering cancer vaccine discovery and development, including one that has been recognised as a \u2018top 100\u2019 poster presentation, at the Society for Immunotherapy of Cancer (SITC) 2024, held in Houston, US, from 6-10th November.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/eterna-biologics-revolutionising-rna-therapeutics?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/eterna-biologics-revolutionising-rna-therapeutics/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"EteRNA Biologics logo\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/eterna-biologics-revolutionising-rna-therapeutics/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/eterna-biologics-revolutionising-rna-therapeutics/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/eterna-biologics-revolutionising-rna-therapeutics/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/eterna-biologics-revolutionising-rna-therapeutics\" title=\"We are excited to welcome Eterna Biologics, a University of Oxford biotech spinout company with a mission to unleash the full potential of RNA medicines. The company aims to enhance global health by expanding the applicability of RNA-targeting medicine to develop treatment for a wide range of human conditions.\" itemprop=\"name\" class=\"state-published\">Eterna Biologics: Revolutionising RNA therapeutics</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">28 August 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">We are excited to welcome Eterna Biologics, a University of Oxford biotech spinout company with a mission to unleash the full potential of RNA medicines. The company aims to enhance global health by expanding the applicability of RNA-targeting medicine to develop treatment for a wide range of human conditions.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/evolvere-biosciences-accepted-into-the-prestigious-y-combinator-program?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/evolvere-biosciences-accepted-into-the-prestigious-y-combinator-program/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"A photo of the Evolvere Biosciences team leaning on the Y Combinator signpost.\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/evolvere-biosciences-accepted-into-the-prestigious-y-combinator-program/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/evolvere-biosciences-accepted-into-the-prestigious-y-combinator-program/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/evolvere-biosciences-accepted-into-the-prestigious-y-combinator-program/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/evolvere-biosciences-accepted-into-the-prestigious-y-combinator-program\" title=\"The team of University of Oxford students is making strides that could transform our approach to antibiotics.\" itemprop=\"name\" class=\"state-published\">Evolvere Biosciences accepted into the prestigious Y Combinator program</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">23 August 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">The team of University of Oxford students is making strides that could transform our approach to antibiotics.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/u-ploid-thrilled-to-join-the-bioescalator-community?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/u-ploid-thrilled-to-join-the-bioescalator-community/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/u-ploid-thrilled-to-join-the-bioescalator-community/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/u-ploid-thrilled-to-join-the-bioescalator-community/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/u-ploid-thrilled-to-join-the-bioescalator-community/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/u-ploid-thrilled-to-join-the-bioescalator-community\" title=\"U-Ploid Biotechnologies joins the BioEscalator to develop groundbreaking therapeutics that improve egg quality and revolutionise IVF.\" itemprop=\"name\" class=\"state-published\">U-Ploid thrilled to join the BioEscalator Community</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">21 August 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">U-Ploid Biotechnologies joins the BioEscalator to develop groundbreaking therapeutics that improve egg quality and revolutionise IVF.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/re-aim-therapeutics-targeting-disease-causal-cells-to-cure-autoimmunity?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/re-aim-therapeutics-targeting-disease-causal-cells-to-cure-autoimmunity/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"Photo of Ash Maroof, Founder and CSO.\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/re-aim-therapeutics-targeting-disease-causal-cells-to-cure-autoimmunity/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/re-aim-therapeutics-targeting-disease-causal-cells-to-cure-autoimmunity/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/re-aim-therapeutics-targeting-disease-causal-cells-to-cure-autoimmunity/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/re-aim-therapeutics-targeting-disease-causal-cells-to-cure-autoimmunity\" title=\"We are delighted to welcome RE-AIM Therapeutics to the BioEscalator community, a start-up focused on developing antibody-based curative therapies for inflammatory disorders, such as psoriasis and inflammatory bowel disease.\" itemprop=\"name\" class=\"state-published\">RE-AIM Therapeutics: Targeting disease causal cells to cure autoimmunity</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">18 July 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">We are delighted to welcome RE-AIM Therapeutics to the BioEscalator community, a start-up focused on developing antibody-based curative therapies for inflammatory disorders, such as psoriasis and inflammatory bowel disease.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/the-bioescalator-welcomes-sigenex-to-its-growing-community?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/the-bioescalator-welcomes-sigenex-to-its-growing-community/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/the-bioescalator-welcomes-sigenex-to-its-growing-community/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/the-bioescalator-welcomes-sigenex-to-its-growing-community/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/the-bioescalator-welcomes-sigenex-to-its-growing-community/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/the-bioescalator-welcomes-sigenex-to-its-growing-community\" title=\"SiGenex is advancing genomic medicine with its innovative, artificial intelligence-powered in-hospital sequencing platform. The company's technology is designed to transform how hospitals, clinics, and medical centres perform targeted next-generation sequencing (NGS) tests.\" itemprop=\"name\" class=\"state-published\">The BioEscalator welcomes SiGenex to its growing community</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">18 July 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">SiGenex is advancing genomic medicine with its innovative, artificial intelligence-powered in-hospital sequencing platform. The company's technology is designed to transform how hospitals, clinics, and medical centres perform targeted next-generation sequencing (NGS) tests.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/bioarchitech-graduates-from-the-bioescalator-a-new-chapter-for-innovative-cancer-therapy?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/bioarchitech-graduates-from-the-bioescalator-a-new-chapter-for-innovative-cancer-therapy/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"A photo of the Bioarchitech team on their last day in the BioEscalator. Left to right: Ines Loureiro, Kevin Maskell, Andri Vasou, and William Jackson.\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/bioarchitech-graduates-from-the-bioescalator-a-new-chapter-for-innovative-cancer-therapy/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/bioarchitech-graduates-from-the-bioescalator-a-new-chapter-for-innovative-cancer-therapy/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/bioarchitech-graduates-from-the-bioescalator-a-new-chapter-for-innovative-cancer-therapy/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\"\n             itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/bioarchitech-graduates-from-the-bioescalator-a-new-chapter-for-innovative-cancer-therapy\" title=\"Bioarchitech's departure from the BioEscalator marks the beginning of an exciting new phase for the pioneering cancer therapy company, as it transitions to the next stage of its innovative journey.\" itemprop=\"name\" class=\"state-published\">Bioarchitech graduates from the BioEscalator: A new chapter for innovative cancer therapy</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">17 July 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Bioarchitech's departure from the BioEscalator marks the beginning of an exciting new phase for the pioneering cancer therapy company, as it transitions to the next stage of its innovative journey.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-grabs-7m-seed-from-felicis-and-yc-to-advance-delivery-of-cancer-treatments?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-grabs-7m-seed-from-felicis-and-yc-to-advance-delivery-of-cancer-treatments/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"Photo: Left to right - Michael Dustin, Professor of Molecular Immunology; Ashwin Jainarayanan, Founder &amp; CSO of Granza Bio; and Ashwin Nandakumar, Founder &amp; CEO of Granza Bio.\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-grabs-7m-seed-from-felicis-and-yc-to-advance-delivery-of-cancer-treatments/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-grabs-7m-seed-from-felicis-and-yc-to-advance-delivery-of-cancer-treatments/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-grabs-7m-seed-from-felicis-and-yc-to-advance-delivery-of-cancer-treatments/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\"\n             itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-grabs-7m-seed-from-felicis-and-yc-to-advance-delivery-of-cancer-treatments\" title=\"In April 2024, the BioEscalator welcomed Granza Bio, a biotech startup focusing on developing novel immunotherapy delivery methods. The company has already attracted investor interest and closed a successful $7.14 million seed funding round led by Felicis and Refactor, with participation from Y Combinator.\" itemprop=\"name\" class=\"state-published\">Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">2 July 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">In April 2024, the BioEscalator welcomed Granza Bio, a biotech startup focusing on developing novel immunotherapy delivery methods. The company has already attracted investor interest and closed a successful $7.14 million seed funding round led by Felicis and Refactor, with participation from Y Combinator.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/medimabbios-graduation-from-the-bioescalator-a-testament-to-innovation-and-growth?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/medimabbios-graduation-from-the-bioescalator-a-testament-to-innovation-and-growth/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/medimabbios-graduation-from-the-bioescalator-a-testament-to-innovation-and-growth/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/medimabbios-graduation-from-the-bioescalator-a-testament-to-innovation-and-growth/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/medimabbios-graduation-from-the-bioescalator-a-testament-to-innovation-and-growth/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/medimabbios-graduation-from-the-bioescalator-a-testament-to-innovation-and-growth\" title=\"MediMab Biotherapeutics announces its graduation from the BioEscalator. This move represents a major milestone for the company as it relocates to Abingdon Science Park, positioning itself for further expansion and cutting-edge research in immuno-oncology.\" itemprop=\"name\" class=\"state-published\">MediMabBio's graduation from the BioEscalator: A testament to innovation and growth</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">5 June 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">MediMab Biotherapeutics announces its graduation from the BioEscalator. This move represents a major milestone for the company as it relocates to Abingdon Science Park, positioning itself for further expansion and cutting-edge research in immuno-oncology.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/integrated-cancer-biotech-infinitopes-secures-12-8m-seed-financing-to-enhance-its-precision-immunomics-tm-antigen-discovery-technologies-to-target-five-more-cancers?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/integrated-cancer-biotech-infinitopes-secures-12-8m-seed-financing-to-enhance-its-precision-immunomics-tm-antigen-discovery-technologies-to-target-five-more-cancers/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"A photo of two Infinitopes scientists working in their laboratory.\"\n             srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/integrated-cancer-biotech-infinitopes-secures-12-8m-seed-financing-to-enhance-its-precision-immunomics-tm-antigen-discovery-technologies-to-target-five-more-cancers/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/integrated-cancer-biotech-infinitopes-secures-12-8m-seed-financing-to-enhance-its-precision-immunomics-tm-antigen-discovery-technologies-to-target-five-more-cancers/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/integrated-cancer-biotech-infinitopes-secures-12-8m-seed-financing-to-enhance-its-precision-immunomics-tm-antigen-discovery-technologies-to-target-five-more-cancers/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/integrated-cancer-biotech-infinitopes-secures-12-8m-seed-financing-to-enhance-its-precision-immunomics-tm-antigen-discovery-technologies-to-target-five-more-cancers\" title=\"Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1\" itemprop=\"name\" class=\"state-published\">Integrated cancer biotech Infinitopes secures \u00a312.8M seed financing to enhance its Precision Immunomics(TM) antigen discovery technologies to target five more cancers</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">30 April 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-pioneering-personalised-and-targeted-cancer-therapeutics?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-pioneering-personalised-and-targeted-cancer-therapeutics/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-pioneering-personalised-and-targeted-cancer-therapeutics/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-pioneering-personalised-and-targeted-cancer-therapeutics/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-pioneering-personalised-and-targeted-cancer-therapeutics/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/granza-bio-pioneering-personalised-and-targeted-cancer-therapeutics\" title=\"The BioEscalator is pleased to welcome Granza Bio, a biotech startup founded by two PhD graduates in oncology and immunology from the University of Oxford. Granza Bio is pioneering a new era in cancer therapeutics by developing personalised and targeted cancer treatments using the body's own immune system.\" itemprop=\"name\" class=\"state-published\">Granza Bio: Pioneering personalised and targeted cancer therapeutics</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">3 April 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">The BioEscalator is pleased to welcome Granza Bio, a biotech startup founded by two PhD graduates in oncology and immunology from the University of Oxford. Granza Bio is pioneering a new era in cancer therapeutics by developing personalised and targeted cancer treatments using the body's own immune system.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-announces-strategic-collaboration-with-immunocore-to-engineer-t-cell-receptors-using-artificial-intelligence?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-announces-strategic-collaboration-with-immunocore-to-engineer-t-cell-receptors-using-artificial-intelligence/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-announces-strategic-collaboration-with-immunocore-to-engineer-t-cell-receptors-using-artificial-intelligence/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-announces-strategic-collaboration-with-immunocore-to-engineer-t-cell-receptors-using-artificial-intelligence/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-announces-strategic-collaboration-with-immunocore-to-engineer-t-cell-receptors-using-artificial-intelligence/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/exogene-announces-strategic-collaboration-with-immunocore-to-engineer-t-cell-receptors-using-artificial-intelligence\" title=\"Exogene, a pioneer in the use of generative artificial intelligence (AI) for T-cell receptor (TCR) engineering, has entered into a research collaboration with industry leader Immunocore Holdings plc (NASDAQ: IMCR), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases.\" itemprop=\"name\" class=\"state-published\">Exogene announces strategic collaboration with Immunocore to engineer T-Cell receptors using artificial intelligence</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">4 March 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Exogene, a pioneer in the use of generative artificial intelligence (AI) for T-cell receptor (TCR) engineering, has entered into a research collaboration with industry leader Immunocore Holdings plc (NASDAQ: IMCR), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-has-a-double-victory-at-the-15th-annual-obn-awards-2023?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-has-a-double-victory-at-the-15th-annual-obn-awards-2023/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"The Infinitopes team is seen posing with one of their trophies in front of an OBN Awards backdrop.\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-has-a-double-victory-at-the-15th-annual-obn-awards-2023/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-has-a-double-victory-at-the-15th-annual-obn-awards-2023/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-has-a-double-victory-at-the-15th-annual-obn-awards-2023/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/infinitopes-has-a-double-victory-at-the-15th-annual-obn-awards-2023\" title=\"The OBN Awards recognise companies that demonstrate outstanding leadership, innovative practices, and significant contributions towards addressing clinical needs at different stages of development.\" itemprop=\"name\" class=\"state-published\">Infinitopes has a double victory at the 15th Annual OBN Awards 2023</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">23 November 2023</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">The OBN Awards recognise companies that demonstrate outstanding leadership, innovative practices, and significant contributions towards addressing clinical needs at different stages of development.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/hutano-diagnostics-acquired-by-edx-medical-group?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/hutano-diagnostics-acquired-by-edx-medical-group/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/hutano-diagnostics-acquired-by-edx-medical-group/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/hutano-diagnostics-acquired-by-edx-medical-group/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/hutano-diagnostics-acquired-by-edx-medical-group/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/hutano-diagnostics-acquired-by-edx-medical-group\" title=\"We are delighted that BioEscalator resident start-up Hutano Diagnostics has announced its acquisition by Cambridge, UK-based EDX Medical Group PLC.\" itemprop=\"name\" class=\"state-published\">Hutano Diagnostics acquired by EDX Medical Group</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">28 September 2023</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">We are delighted that BioEscalator resident start-up Hutano Diagnostics has announced its acquisition by Cambridge, UK-based EDX Medical Group PLC.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/oxford-silk-phage-technologies-secures-top-spot-in-biocap-2023-pitch-competition?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/oxford-silk-phage-technologies-secures-top-spot-in-biocap-2023-pitch-competition/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"Stephanie Lesage, the CEO and Co-founder of Oxford Silk Phage Technologies is pictured holding the BioCap 2023 trophy.\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/oxford-silk-phage-technologies-secures-top-spot-in-biocap-2023-pitch-competition/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/oxford-silk-phage-technologies-secures-top-spot-in-biocap-2023-pitch-competition/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/oxford-silk-phage-technologies-secures-top-spot-in-biocap-2023-pitch-competition/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/oxford-silk-phage-technologies-secures-top-spot-in-biocap-2023-pitch-competition\" title=\"Despite facing tough competition, Oxford Silk Phage Technologies impressed the judges with its presentation, earning the top spot in the competition.\" itemprop=\"name\" class=\"state-published\">Oxford Silk Phage Technologies wins BioCap 2023 pitch competition</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">28 September 2023</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Despite facing tough competition, Oxford Silk Phage Technologies impressed the judges with its presentation, earning the top spot in the competition.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alethiomics-and-infinitopes-shortlisted-in-the-new-startup-of-the-year-category-for-the-cancer-research-horizons-innovation-entrepreneurship-awards-2022?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alethiomics-and-infinitopes-shortlisted-in-the-new-startup-of-the-year-category-for-the-cancer-research-horizons-innovation-entrepreneurship-awards-2022/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"Cancer Research Horizons logo\"\n             srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alethiomics-and-infinitopes-shortlisted-in-the-new-startup-of-the-year-category-for-the-cancer-research-horizons-innovation-entrepreneurship-awards-2022/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/alethiomics-and-infinitopes-shortlisted-in-the-new-startup-of-the-year-category-for-the-cancer-research-horizons-innovation-entrepreneurship-awards-2022/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/alethiomics-and-infinitopes-shortlisted-in-the-new-startup-of-the-year-category-for-the-cancer-research-horizons-innovation-entrepreneurship-awards-2022/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alethiomics-and-infinitopes-shortlisted-in-the-new-startup-of-the-year-category-for-the-cancer-research-horizons-innovation-entrepreneurship-awards-2022\" title=\"Alethiomics is uncovering new biology to discover and develop life-changing treatments for patients with blood cancer, and Infinitopes is identifying hidden tumour targets, enabling the creation of high-efficiency vaccines.\" itemprop=\"name\" class=\"state-published\">Alethiomics and Infinitopes shortlisted in the New Startup of the Year category for the Cancer Research Horizons Innovation &amp; Entrepreneurship Awards 2022</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">5 December 2022</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Alethiomics is uncovering new biology to discover and develop life-changing treatments for patients with blood cancer, and Infinitopes is identifying hidden tumour targets, enabling the creation of high-efficiency vaccines.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/ospt-selected-by-incateurope-as-one-of-the-6-new-ventures-to-receive-stage-i-support?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/ospt-selected-by-incateurope-as-one-of-the-6-new-ventures-to-receive-stage-i-support/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"Image of bacteriophage viruses\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/ospt-selected-by-incateurope-as-one-of-the-6-new-ventures-to-receive-stage-i-support/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/ospt-selected-by-incateurope-as-one-of-the-6-new-ventures-to-receive-stage-i-support/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/ospt-selected-by-incateurope-as-one-of-the-6-new-ventures-to-receive-stage-i-support/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/ospt-selected-by-incateurope-as-one-of-the-6-new-ventures-to-receive-stage-i-support\" title=\"This new funding will help OSPT refine its regulatory strategy.\" itemprop=\"name\" class=\"state-published\">OSPT selected by INCATEurope as one of the 6 new ventures to receive Stage I support</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">23 August 2022</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">This new funding will help OSPT refine its regulatory strategy.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/introducing-oxford-cancer-analytics?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/introducing-oxford-cancer-analytics/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/introducing-oxford-cancer-analytics/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/news-and-events/news/introducing-oxford-cancer-analytics/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/news-and-events/news/introducing-oxford-cancer-analytics/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/introducing-oxford-cancer-analytics\" title=\"OXcan, short for Oxford Cancer Analytics, uses machine learning techniques combined with cutting-edge liquid biopsy techniques, to search for stage one lung cancer biomarkers.\" itemprop=\"name\" class=\"state-published\">Introducing Oxford Cancer Analytics</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">21 June 2022</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news\" title=\"Tenant news\">\n\t\t                <span class=\"label label-primary\">Tenant news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">OXcan, short for Oxford Cancer Analytics, uses machine learning techniques combined with cutting-edge liquid biopsy techniques, to search for stage one lung cancer biomarkers.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n"
    ], 
    "more": "\n\n    \n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=tenant-news&amp;random=24e824e0-1fd7-4de7-88f7-2c7f429918d3&amp;b_start:int=40&amp;format=json\" title=\"Load more\" class=\"btn btn-default load-more-button\">\n            Load More\n        </a>\n    \n\n", 
    "msg": ""
}